News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AnaSpec, Inc. Introduces SensoLyte® Beta-Amyloid ELISA Kits


5/29/2012 11:53:31 AM

Fremont CA – May 29, 2012 -- AnaSpec, EGT Group is pleased to announce the release of the SensoLyte® ELISA kits for the quantification of human and mouse/rat ß-Amyloid (1-40) or (1-42) peptide. Compared to similar kits in the industry, these kits are a one-step assay optimized to detect human or mouse/rat beta-Amyloid (1-40) and (1-42) peptides, respectively. Test samples can be from brain lysate, cerebrospinal fluid, plasma, serum or saliva with assay time in as short as one hour (excluding incubation times). A 96-well plate with wells pre-coated with monoclonal anti-ß-Amyloid (1-40) or (1-42) specific capture antibodies and blocked with a proprietary blocking solution is included in each kit. These kits are highly sensitive, specific and reproducible. Ample materials and reagents are provided to measure 80 samples in a 96-well plate format. Dr. Patrick L. McGeer (Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada) feedbacks as kits are reliable and simple to use with reproducible results.

For more information, please visit http://www.anaspec.com/products/promotions.asp?col=1&row=1

AnaSpec, EGT Group

AnaSpec, Eurogentec Group is a leading provider of integrated proteomics and genomics solutionsTM for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCRs. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.

For more information visit www.anaspec.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES